Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-18T08:47:30.212Z Has data issue: false hasContentIssue false
  • English
  • Français

The Clinical Correlates of Neurological Soft Signs in Chronic Schizophrenia

Published online by Cambridge University Press:  02 January 2018

D. J. King ,
A. Wilson ,
S. J. Cooper  and
J. L. Waddington
D. J. King*
Affiliation:
Department of Therapeutics and Pharmacology, The Queen's University of Belfast, and Holywell Hospital, Antrim
A. Wilson
Affiliation:
Department of Mental Health, The Queen's University of Belfast
S. J. Cooper
Affiliation:
Department of Mental Health, The Queen's University of Belfast
J. L. Waddington
Affiliation:
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin
*
∗Department of Therapeutics and Pharmacology, The Whitla Medical Building, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland
Get access Rights & Permissions [Opens in a new window]

Abstract

Among 16 chronic schizophrenic in-patients, all had at least one neurological soft sign (NSS), and 6 (40%) had definite neurodysfunction. NSS and TD scores were highly intercorrelated, and NSS were significantly correlated with neuroleptic drug exposure. NSS correlated positively with both positive and negative symptoms and cognitive impairment but not with cerebral ventricular size on CT. Patients with neurodysfunction had more positive and negative psychopathology, cognitive impairment and TD than those without. Cerebral ventricular sizes and family histories of schizophrenia were similar in both NSS groups. The presence of NSS may be a simple but important way of identifying a subgroup of schizophrenics with neurodevelopmental predisposing abnormalities, and vulnerability to TD.

Type
Papers
Information
The British Journal of Psychiatry , Volume 158 , Issue 6 , June 1991 , pp. 770 - 775
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1960) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM–III). Washington, DC: APA.Google Scholar
Cadet, J. L., Rickler, K. C. & Weinberger, D. R. (1986) The clinical neurological examination in schizophrenia. In The Neurology of Schizophrenia (eds H. A. Nasrallah & D. R. Weinberger), pp. 1–49. Amsterdam: Elsevier.Google Scholar
Cooper, S. J. & King, D. J. (1987) Is schizophrenia a neurodevelopment disorder? British Medical Journal, 295, 1068.CrossRefGoogle Scholar
Cox, S. M. & Ludwig, A. M. (1979) Neurological soft signs and psychopathology. I. Findings in schizophrenia. Journal of Nervous and Mental Disease, 167, 161–165.CrossRefGoogle ScholarPubMed
Davis, J. M. (1976) Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry, 33, 858–861.Google Scholar
Erlenmeyer-Kimling, L., Cornblatt, B., Friedman, D., et al (1982) Neurological, electrophysiological, and attentional deviations in children at risk for schizophrenia. In Schizophrenia as a Brain Disease (eds F. A. Henn & H. A. Nasrallah), pp. 61–98. Oxford: Oxford University Press.Google Scholar
Gureje, O. (1988) Neurological soft signs in Nigerian schizophrenics: a controlled study. Acta Psychiatrica Scandinavica, 78, 505–509.Google Scholar
Heinrichs, D. W. & Buchanan, R. W. (1988) Significance and meaning of neurological signs in schizophrenia. American Journal of Psychiatry, 145, 11–18.Google Scholar
Johnstone, E. C., Frith, C. D., Crow, T. J., et al (1978) Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet, i, 848–851.Google Scholar
Keshavan, M. S. & Yeragani, V. K. (1987) Primitive reflexes in psychiatry. Lancet, i, 1264.Google Scholar
King, D. J., Cooper, S. J., Earle, J. A. P., et al (1985) Serum and CSF antibody titres to seven common viruses in schizophrenic patients. British Journal of Psychiatry, 147, 145–149.Google Scholar
Kinney, D. K., Woods, B. T. & Yurgelun-Todd, D. (1986) Neurologic abnormalities in schizophrenic patients and their families. II. Neurologic and psychiatric findings in relatives. Archives of General Psychiatry, 43, 665–668.CrossRefGoogle ScholarPubMed
Kolakowska, T., Williams, A. O., Jambor, K., et al (1985) Schizophrenia with good and poor outcome. III. Neurological ‘soft’ signs, cognitive impairment and their clinical significance. British Journal of Psychiatry, 146, 348–357.CrossRefGoogle ScholarPubMed
Krawiecka, M., Goldberg, D. & Vaughan, M. (1977) A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinavica, 55, 299–308.CrossRefGoogle ScholarPubMed
Liddle, P. F. (1987) Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychological Medicine, 17, 49–57.CrossRefGoogle ScholarPubMed
Marsalek, M., David, I., Pavlat, J., et al (1988) The signs of brain vulnerability in tardive dyskinesia. Schizophrenia Research, 1, 231.Google Scholar
Mosher, L. R., Pollin, W. & Stabenau, J. R. (1971) Identical twins discordant for schizophrenia. Neurological findings. Archives of General Psychiatry, 24, 422–430.CrossRefGoogle Scholar
Murray, R. M., Lewis, S. W. & Reveley, A. M. (1985) Towards an aetiological classification of schizophrenia. Lancet, i, 1023–1026.Google Scholar
Murray, R. M. & Lewis, S. W. (1987) Is schizophrenia a neurodevelopmental disorder? British Medical Journal, 295, 681–682.CrossRefGoogle ScholarPubMed
Murray, R. M., Lewis, S. W., Owen, M. J., et al (1988) The neurodevelopmental origins of dementia praecox. In Schizophrenia: The Major Issues (eds P. Bebbington & P. McGuffin), pp. 90–106. Oxford: Heinemann.Google Scholar
Nasrallah, H. A., Tippin, J. & McCalley-Whitters, M. (1982) Neurological soft signs in manic patients: A comparison with schizophrenics and control groups. Journal of Clinical Psychiatry, 43, 310–312.Google Scholar
Nasrallah, H. A., Olson, S. C., McCalley-Whitters, M., et al (1986) Cerebral ventricular enlargement in schizophrenia. Archives of General Psychiatry, 43, 157–159.CrossRefGoogle ScholarPubMed
National Institute of Mental Health (1976) Abnormal involuntary movement scale. In ECDEU Assessment Manual (ed. W. Guy), pp. 534–537. Rockville: US Department of Health, Education and Welfare.Google Scholar
Owens, D. G. C., Johnstone, E. C., Crow, T. J., et al (1985) Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations. Psychological Medicine, 15, 27–41.CrossRefGoogle Scholar
Quitkin, F., Rifkin, A. & Klein, D. F. (1976) Neurologic soft signs in schizophrenia and character disorders. Archives of General Psychiatry, 33, 845–853.Google Scholar
Quitkin, F., Klein, D. & Rifkin, A. (1985) Schizophrenia with good and poor outcome. British Journal of Psychiatry, 147, 455–456.Google Scholar
Romani, A., Merello, S., Gozzoli, L., et al (1987) P300 and CT scan in patients with chronic schizophrenia. British Journal of Psychiatry, 151, 506–513.Google Scholar
Schooler, N. R. & Kane, J. M. (1982) Research diagnoses for tardive dyskinesia. Archives of General Psychiatry, 39, 486–487.Google ScholarPubMed
Smeraldi, E., Gambini, O., Bellodi, L., et al (1987) Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. Psychiatry Research, 21, 293–301.Google Scholar
Suy, E., Woestenborghs, R. & Heykants, J. (1982) Bioavailability and clinical effect of two different concentrations of haloperidol decanoate. Current Therapeutic Research, 31, 982–991.Google Scholar
Taylor, M. A. & Abrams, R. (1984) Cognitive impairment in schizophrenia. American Journal of Psychiatry, 141, 196–201.Google ScholarPubMed
Torrey, E. F. (1980) Neurological abnormalities in schizophrenic patients. Biological Psychiatry, 15, 381–388.Google Scholar
Waddington, J. L. (1987) Tardive dyskinesia in schizophrenia and other disorders: associations with ageing, cognitive dysfunction and structural brain pathology in relation to neuroleptic exposure. Human Psychopharmacology, 2, 11–22.Google Scholar
Waddington, J. L., O'Boyle, K. M., Molloy, A. G., et al (1985) Neurotransmitter receptors and ageing: dopamine/neuroleptic receptors, involuntary movements and the disease process of schizophrenia. In Therapeutics in the Elderly (eds K. O'Malley & J. L. Waddington), pp. 63–76. Amsterdam: Elsevier.Google Scholar
Walker, E. (1981) Attentional and neuromotor functions of schizophrenics, schizoaffectives, and patients with other affective disorders. Archives of General Psychiatry, 38, 1355–1358.Google Scholar
Wegner, J. T., Catalano, F., Gibralter, J., et al (1985) Schizophrenics with tardive dyskinesia: neuropsychological deficit and family psychopathology. Archives of General Psychiatry, 42, 860–865.Google Scholar
Weinberger, D. R. (1988) Premorbid neuropathology in schizophrenia. Lancet, ii, 445.Google Scholar
Weinberger, D. R. & Wyatt, R. J. (1982) Cerebral ventricular size: a biological marker for sub-typing chronic schizophrenia. In Biological Markers in Psychiatry and Neurology (ed. E. Usdin), pp. 505–512. Oxford: Pergamon Press.Google Scholar
Williams, A. O., Reveley, M. A., Kolakowska, T., et al (1985) Schizophrenia with good and poor outcome. II: Cerebral ventricular size and its clinical significance. British Journal of Psychiatry, 146, 239–246.Google Scholar
Withers, E. & Hinton, J. (1971) Three forms of the clinical tests of the sensorium and their reliability. British Journal of Psychiatry, 119, 1–8.Google Scholar
Woods, B. T. & Short, M. P. (1985) Neurological dimensions of psychiatry. Biological Psychiatry, 20, 192–198.Google Scholar
Woods, B. T., Kinney, D. K. & Yurgelun-Todd, D. (1986) Neurologic abnormalities in schizophrenic patients and their families. I. Comparison of schizophrenic, bipolar and substance abuse patients and normal controls. Archives of General Psychiatry, 43, 657–663.CrossRefGoogle ScholarPubMed
Youssef, H. A. & Waddington, J. L. (1988) Primitive (developmental) reflexes and diffuse cerebral dysfunction in schizophrenia and bipolar affective disorder: over-representation in patients with tardive dyskinesia. Biological Psychiatry, 23, 791–796.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.